Tricyclic compounds
The invention provide a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomer and isomer thereof wherein the variable are defined herein. The compound of the invention are useful for treating immunological and oncological conditions.
1. A method of preparing a compound of Formula (Ia)
or pharmaceutically acceptable salts, stereoisomer or isomer thereof, comprising:
converting a compound of Formula 2
into the compound of (Ia), wherein
R p is a hydrogen, —SO 2 N(CH 3 ) 2 , —SO 2 (2,4,6-trimethylphenyl), —SO 2 phenyl, —SO 2 (4-butylphenyl), —SO 2 (4-methylphenyl), —SO 2 (4-methoxyphenyl), —C(O)OCH 2 CCl 3 , —C(O)OCH 2 CH 2 Si(CH 3 ) 3 , —C(O)OC(CH 3 ) 3 , —C(O)OC(CH 3 ) 2 (CCl 3 ), —C(O)O—1-adamantyl, —CH═CH 2 , —CH 2 CH 2 Cl, —CH(OCH 2 CH 3 )CH 3 , —CH 2 CH 2 -2-pyridyl, —CH 2 CH 2 -4-pyridyl, —Si(C(CH 3 ) 3 )(CH 3 ) 2 , —Si(CH(CH 3 ) 2 ) 3 , —CH 2 phenyl, —CH 2 (4-CH 3 O-phenyl), —CH 2 (3,4-di-methoxyphenyl), —CH 2 (2-Nitrophenyl), -(2,4-dinitrophenyl), —CH 2 C(O)phenyl, —C(phenyl) 3 , —CH(phenyl) 2 , —C(phenyl) 2 (4-pyridyl), —N(CH 3 ) 2 , —CH 2 OH, —CH 2 OCH 3 , —CH(OCH 2 CH 3 ) 2 , —CH 2 OCH 2 CH 2 Cl, —CH 2 OCH 2 CH 2 Si(CH 3 ) 3 , —CH 2 OC(CH 3 ) 3 , —CH 2 OC(O)C(CH 3 ) 3 , —CH 2 OCH 2 phenyl, -(2-tetrahydropyranyl), —C(O)H, or —P(S)(phenyl) 2 ;
R 1 , R 2 and R 5 are each independently hydrogen, deuterium, —N(R a )(R b ), halogen, —OR a , —SR a , —S(O)R a , —S(O) 2 R a , —NO 2 , —C(O)OR a , —CN, —C(O)N(R a )(R b ), —N(R a )C(O)(R b ), —C(O)R a , —C(OH)R a R b , —N(R a )S(O) 2 —R b , —S(O) 2 N(R a )(R b ), —CF 3 , —OCF 3 , optionally substituted (C 1 -C 6 )alkyl, optionally substituted (C 2 -C 6 )alkenyl, optionally substituted (C 2 -C 6 )alkynyl, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 1 -C 10 )heteroaryl, optionally substituted (C 1 -C 10 )heterocyclyl, or optionally substituted (C 6 -C 10 )aryl;
wherein in a moiety containing —N(R a )(R b ), the nitrogen, R a and R b may form a ring such that —N(R a )(R b ) represents an optionally substituted (C 2 -C 10 )heterocyclyl or optionally substituted (C 1 -C 10 )heteroaryl linked through a nitrogen;
R 3 is hydrogen, an optionally substituted bridged (C 5 -C 12 )cycloalkyl, optionally substituted bridged (C 2 -C 10 )heterocyclyl, optionally substituted (C 1 -C 8 )alkyl, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 3 -C 8 )cycloalkenyl, optionally substituted (C 6 -C 10 )aryl, optionally substituted (C 1 -C 10 )heteroaryl, optionally substituted (C 2 -C 10 )heterocyclyl; or
R 3 is -A-D-E-G, wherein:
A is a bond, —C(O)—, optionally substituted (C 1 -C 6 )alkylene, optionally substituted (C 2 -C 6 )alkenylene, optionally substituted (C 2 -C 6 )alkynylene, optionally substituted (C 3 -C 12 )cycloalkylene, optionally substituted (C 2 -C 6 )heterocyclylene, —C(O)N(R a )—R e —, —N(R a )C(O)—R e —, —O—R e —, —N(R a )—R e —, —S—R e —, —S(O) 2 —R e —, —S(O)R e —, —C(O—R a )(R b )—R e —, —S(O) 2 N(R a )—R e —, —N(R a )S(O) 2 —R e — or —N(R a )C(O)N(R b )—R e —;
D is an optionally substituted (C 1 -C 8 )alkylene, optionally substituted bridged (C 5 -C 12 )cycloalkylene, optionally substituted (C 3 C 10 ) cycloalkylene, optionally substituted bridged (C 5 -C 10 )cycloalkenylene, optionally substituted (C 3 -C 10 )cycloalkenylene, optionally substituted (C 6 -C 10 )arylene, optionally substituted (C 1 -C 10 )heteroarylene, optionally substituted bridged (C 2 -C 10 )heterocyclylene or an optionally substituted (C 2 -C 10 )heterocyclylene;
E is a bond, —R e —, —R e —C(O)—R e —, —R e —C(O)C(O)—R e —, —R e —C(O)O—R e —, —R e —C(O)C(O)N(R a )—R e —, —R e —N(R a )—C(O)C(O)—R e —, —R e —O—R e —, —R e —S(O) 2 —R e —, —R e —S(O)—R e —, —R e —S—R e —, —R e —N(R a )—R e —, —R e —N(R a )C(O)—R e —, —R e C(O)N(R a )R e —, —R e —OC(O)N(R a )—R e —, —R e —N(R a )C(O)OR e —, —R e —OC(O)—R e , —R e —N(R a )C(O)N(R b )—R e —, —R e —N(R a )S(O) 2 —R e —, or —R e —S(O) 2 N(R a )—R e —; or
E is
where in all cases, E is linked to either a carbon or a nitrogen atom in D;
G is hydrogen, deuterium, —N(R a )(R b ), halogen, —OR a , —SR a , —S(O)R a , —S(O) 2 R a , —NO 2 , —C(O)OR a , —CN, —C(O)N(R a )(R b ), —N(R a )C(O)R b , —N(R a )C(O)OR b , —OC(O)N(R a ), —N(R a )C(O)N(R b ) 2 , —C(O-R a )(R b ) 2 , —C(O)R a , —CF 3 , —OCF 3 , —N(R a )S(O) 2 R b , —S(O) 2 N(R a )(R b ), —S(O) 2 N(R a )C(O)R b , an optionally substituted —(C 1 -C 6 )alkyl, an optionally substituted —(C 2 -C 6 )alkenyl, an optionally substituted —(C 2 -C 6 )alkynyl, an optionally substituted —(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 10 )heteroaryl, an optionally substituted —(C 1 -C 10 )heterocyclyl, an optionally substituted —(C 6 C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkyl-(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 6 )alkyl-(C 6 -C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkyl-(C 1 -C 10 )heteroaryl, or an optionally substituted —(C 1 -C 6 )alkyl-(C 1 -C 10 )heterocyclyl;
wherein in a moiety containing —N(R a )(R b ), the nitrogen, R a and R b may form a ring such that —N(R a )(R b ) represents an optionally substituted (C 2 -C 10 )heterocyclyl or an optionally substituted (C 1 -C 10 ) heteroaryl linked through a nitrogen;
R a and R b are each independently hydrogen, deuterium, an optionally substituted (C 1 -C 10 )alkyl, an optionally substituted (C 2 -C 10 )alkenyl, an optionally substituted (C 2 -C 10 )alkynyl, an optionally substituted (C 1 -C 10 )alkyl-O—(C 1 -C 10 )alkyl, an optionally substituted (C 3 -C 10 )cycloalkyl, an optionally substituted (C 6 -C 10 )aryl, an optionally substituted (C 1 -C 10 )heteroaryl, an optionally substituted (C 1 -C 10 )heterocyclyl, an optionally substituted —(C 1 -C 6 )alkylene-(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 6 )alkylene-(C 6 -C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkylene-(C 1 -C 10 )heteroaryl, or an optionally substituted —(C 1 -C 6 )alkylene-(C 1 -C 10 )heterocyclyl; and
R e for each occurrence is independently a bond, an optionally substituted (C 1 -C 10 )alkylene, an optionally substituted (C 2 -C 10 )alkenylene, an optionally substituted (C 2 -C 10 )alkynylene, an optionally substituted —(C 1 -C 10 )alkylene-O—(C 1 -C 10 )alkylene group, an optionally substituted (C 3 -C 10 )cycloalkylene, an optionally substituted (C 6 -C 10 )arylene, an optionally substituted (C 1 -C 10 )heteroarylene, or an optionally substituted (C 1 -C 10 )heterocyclylene.
2. The method of claim 1 , comprising converting the compound of Formula 2 to compound 6 of the following structure:
and further comprising converting compound 6 to the compound of Formula (Ia), wherein
RP i—SO 2 N(CH 3 ) 2 , —SO 2 (2,4,6-trimethylphenyl), —SO 2 phenyl, —SO 2 (4-butylphenyl), —SO 2 (4-methylphenyl), —SO 2 (4-methoxyphenyl), —C(O)OCH 2 CCl 3 , —C(O)OCH 2 CH 2 Si(CH 3 ) 3 , —C(O)OC(CH 3 ) 3 , —C(O)OC(CH 3 ) 2 (CCl 3 ), —C(O)O—1-adamantyl, —CH═CH 2 , —CH 2 CH 2 Cl, —CH(OCH 2 CH 3 )CH 3 , —CH 2 CH 2 -2-pyridyl, —CH 2 CH 2 -4-pyridyl, —Si(C(CH 3 ) 3 )(CH 3 ) 2 , —Si(CH(CH 3 ) 2 ) 3 , —CH 2 phenyl, —CH 2 (4-CH 3 O-phenyl), —CH 2 (3,4-di-methoxyphenyl), —CH 2 (2-nitrophenyl), -(2,4-dinitrophenyl), —CH 2 C(O)phenyl, —C(phenyl) 3 , —CH(phenyl) 2 , —C(phenyl) 2 (4-pyridyl), —N(CH 3 ) 2 , —CH 2 OH, —CH 2 OCH 3 , —CH(OCH 2 CH 3 ) 2 , —CH 2 OCH 2 CH 2 Cl, —CH 2 OCH 2 CH 2 Si(CH 3 ) 3 , —CH 2 OC(CH 3 ) 3 , —CH 2 OC(O)C(CH 3 ) 3 , —CH 2 OCH 2 phenyl, -(2-tetrahydropyranyl), —C(O)H, or —P(S)(phenyl) 2 .
3. The method of claim 2 , wherein R P is —SO 2 N(CH 3 ) 2 , —SO 2 (2,4,6-trimethylphenyl), —SO 2 phenyl, —SO 2 (4-butylphenyl), —SO 2 (4-methylphenyl), or —SO 2 (4-methoxyphenyl).
4. The method of claim 3 , wherein
R l and R 2 are each independently hydrogen, deuterium, —N(R a )(R b ), halogen, —OR a , —SR a , —S(O)R a , —S(O) 2 R a , —NO 2 , —C(O)OR a , —CN, —C(O)N(R a )(R b ), —N(R a )C(O)(R b ), —C(O)R a , —C(OH)R a R b , —N(R a )S(O) 2 —R b , —S(O) 2 N(R a )(R b ), —CF 3 , —OCF 3 , optionally substituted (C 1 -C 6 )alkyl, optionally substituted (C 2 -C 6 )alkenyl, optionally substituted (C 2 -C 6 )alkynyl, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 1 -C 10 )heteroaryl, optionally substituted (C 1 -C 10 ) heterocyclyl, or optionally substituted (C 6 -C 10 )aryl;
R 5 is hydrogen, deuterium, —N(R a )(R b ), halogen, —SR a , —S(O)R a , —S(O) 2 R a , —NO 2 , —C(O)OR a , —CN, —C(O)N(R a )(R b ), —N(R a )C(O)(R b ), —C(O)R a , —C(OH)R a R b , —N(R a )S(O) 2 —R b , —S(O) 2 N(R a )(R b ), —CF 3 , —OCF 3 , optionally substituted (C 1 -C 6 )alkyl, optionally substituted (C 2 -C 6 )alkenyl, optionally substituted (C 2 -C 6 )alkynyl, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 1 -C 10 )heteroaryl, optionally substituted (C 1 -C 10 ) heterocyclyl, or optionally substituted (C 6 -C 10 )aryl;
wherein in a moiety containing —N(R a )(R b ), the nitrogen, R a and R b may form a ring such that —N(R a )(R b ) represents an optionally substituted (C 2 -C 10 )heterocyclyl or optionally substituted (C 1 -C 10 )heteroaryl linked through a nitrogen;
R 3 is an optionally substituted bridged (C 5 -C 12 )cycloalkyl, optionally substituted bridged (C 2 -C 10 )heterocyclyl, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 3 -C 8 )cycloalkenyl, optionally substituted (C 6 -C 10 )aryl, optionally substituted (C 1 -C 10 )heteroaryl, optionally substituted (C 2 -C 10 )heterocyclyl; or
R 3 is -A-D-E-G, wherein:
A is a bond, —C(O)—, optionally substituted (C 1 -C 6 )alkylene, optionally substituted (C 2 -C 6 )alkenylene, optionally substituted (C 2 -C 6 )alkynylene, optionally substituted (C 3 -C 12 )cycloalkylene, optionally substituted (C 2 -C 6 )heterocyclylene, —C(O)N(R a )—R e —, —N(R a )C(O)—R e —, —O—R e —, —N(R a )—R e —, —S—R e —, —S(O) 2 —R e —, —S(O)R e —, —C(O—R a )(R b )—R e —, —S(O) 2 N(R a )—R e —, —N(R a )S(O) 2 —R e — or —N(R a )C(O)N(R b )—R e —;
D is optionally substituted bridged (C 5 -C 12 )cycloalkylene, optionally substituted (C 3 -C 10 )cycloalkylene, optionally substituted bridged (C 5 -C 10 )cycloalkenylene, optionally substituted (C 3 -C 10 )cycloalkenylene, optionally substituted (C 6 -C 10 )arylene, optionally substituted (C 1 -C 10 )heteroarylene, optionally substituted bridged (C 2 -C 10 )heterocyclylene or an optionally substituted (C 2 -C 10 )heterocyclylene;
E is a bond, —R e —, —R e —C(O)—R e —, —R e —C(O)C(O)—R e —, —R e —C(O)O-R e —, —R e —C(O)C(O)N(R a )—R e —, —R e —N(R a )—C(O)C(O)—R e —, —R e —O—R e —, —R e —S(O) 2 —R e —, —R e —S(O)—R e —, —R e —S—R e —, —R e —N(R a )—R e —, —R e —N(R a )C(O)—R e —, —R e C(O)N(R a )R e —, —R e —OC(O)N(R a )—R e —, —R e —N(R a )C(O)OR e —, —R e —OC(O)—R e , —R e —N(R a )C(O)N(R b )—R e —, —R e —N(R a )S(O) 2 —R e —, or —R e —S(O) 2 N(R a )—R e —; or
E is
where in all cases, E is linked to either a carbon or a nitrogen atom in D;
G is hydrogen, deuterium, —N(R a )(R b ), halogen, —OR a , —SR a , —S(O)R a , —S(O) 2 R a , —NO 2 , —C(O)OR a , —CN, —C(O)N(R a )(R b ), —N(R a )C(O)R b , —N(R a )C(O)OR b , —OC(O)N(R a ), —N(R a )C(O)N(R b ) 2 , —C(O—R a )(R b ) 2 , —C(O)R a , —CF 3 , —OCF 3 , —N(R a )S(O) 2 R b , —S(O) 2 N(R a )(R b ), —S(O) 2 N(R a )C(O)R b , an optionally substituted —(C 1 -C 6 )alkyl, an optionally substituted —(C 2 -C 6 )alkenyl, an optionally substituted —(C 2 -C 6 )alkynyl, an optionally substituted —(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 10 )heteroaryl, an optionally substituted —(C 1 -C 10 ) heterocyclyl, an optionally substituted —(C 6 -C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkyl-(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 6 )alkyl-(C 6 -C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkyl-(C 1 -C 10 )heteroaryl, or an optionally substituted —(C 1 -C 6 )alkyl-(C 1 -C 10 )heterocyclyl;
wherein in a moiety containing —N(R a )(R b ), the nitrogen, R a and R b may form a ring such that —N(R a )(R b ) represents an optionally substituted (C 2 -C 10 )heterocyclyl or an optionally substituted (C 1 -C 10 ) heteroaryl linked through a nitrogen;
R a and R b are each independently hydrogen, deuterium, an optionally substituted (C 1 -C 10 )alkyl, an optionally substituted (C 2 -C 10 )alkenyl, an optionally substituted (C 2 -C 10 )alkynyl, an optionally substituted (C 1 -C 10 )alkyl-O—(C 1 -C 10 )alkyl, an optionally substituted (C 3 -C 10 )cycloalkyl, an optionally substituted (C 6 -C 10 )aryl, an optionally substituted (C 1 -C 10 )heteroaryl, an optionally substituted (C 1 -C 10 )heterocyclyl, an optionally substituted —(C 1 -C 6 )alkylene-(C 3 -C 10 )cycloalkyl, an optionally substituted —(C 1 -C 6 )alkylene-(C 6 -C 10 )aryl, an optionally substituted —(C 1 -C 6 )alkylene-(C 1 -C 10 )heteroaryl, or an optionally substituted —(C 1 -C 6 )alkylene-(C 1 -C 10 )heterocyclyl; and
R e for each occurrence is independently a bond, an optionally substituted (C 1 -C 10 )alkylene, an optionally substituted (C 2 -C 10 )alkenylene, an optionally substituted (C 2 -C 10 )alkynylene, an optionally substituted —(C 1 -C 10 )alkylene-O—(C 1 -C 10 )alkylene group, an optionally substituted (C 3 -C 10 )cycloalkylene, an optionally substituted (C 1 -C 10 )heteroarylene, or an optionally substituted (C 1 -C 10 )heterocyclylene.
5. The method of claim 4 , wherein R 1 , R 2 , and R 5 are each independently hydrogen or an optionally substituted —(C 1 -C 4 )alkyl.
6. The method of claim 5 , wherein R 3 is an optionally substituted bridged (C 5 -C 12 )cycloalkyl group, optionally substituted bridged (C 2 -C 10 )heterocyclyl group, optionally substituted (C 3 -C 10 )cycloalkyl, optionally substituted (C 6 -C 10 )aryl, optionally substituted (C 1 -C 10 )heteroaryl or optionally substituted (C 2 -C 10 ) heterocyclyl.
7. The method of claim 6 , wherein R 3 is optionally substituted cyclopropyl, optionally substituted cyclobutyl, optionally substituted cyclopentyl, optionally substituted cyclohexyl, optionally substituted phenyl, optionally substituted adamantanyl, optionally substituted azetidinyl, optionally substituted bicyclo[2.1.1]hexyl, optionally substituted bicyclo[2.2.1]heptyl, optionally substituted bicyclo[2.2.2]octyl, optionally substituted bicyclo[3.2.11octyl, optionally substituted bicyclo[3.1.1]heptyl, optionally substituted azabicyclo[3.2.11octanyl, optionally substituted azabicyclo[2.2.1]heptanyl, optionally substituted 2-azabicyclo[3.2.11octanyl, optionally substituted azabicyclo[3.2.2]nonanyl, optionally substituted bicyclo[2.2.1]hept-2-enyl, optionally substituted piperidinyl, optionally substituted pyrrolidinyl or optionally substituted tetrahydrofuranyl.
8. The method of claim 5 , wherein R 3 is A-D-E-G and A is a bond, —C(O)—, optionally substituted (C 1 -C 6 )alkylene, —C(O)N(R a )—R e —, —N(R a )C(O)—R e —, —O—, —N(R a )—, —S—, —C(O—R a )(R b )—R e —, —S(O) 2 N(R a )—, —N(R a )S(O) 2 —or —N(R a )C(O)N(R b )—.
9. The method of claim 8 , wherein D is an optionally substituted azetidinyl, optionally substituted bicyclo[2.2.2]octanylene, optionally substituted bicyclo[2.2.1]heptylene, optionally substituted bicyclo[2.1.1]hexylene, optionally substituted cyclobutylene, optionally substituted cyclopentylene, optionally substituted cyclohexylene, optionally substituted bicyclo[2.2.1]hept-2-enylene, optionally substituted piperidinyl, or optionally substituted pyrrolidinyl.
10. The method of claim 9 , wherein E is —R e —C(O)—R e —, R e —O—R e , —R e —S(O) 2 —R e —, —R e —N(R a )—R e , —R e —N(R a )C(O)—R e —, —R e —C(O)N(R a )R e —, —R e —N(R a )S(O) 2 —R e —, or —R e —S(O) 2 N(R a )R e —.
11. The method of claim 10 , wherein G is —OR a , —CN, —N(R a )S(O) 2 R b , —S(O) 2 N(R a )(R b ), optionally substituted (C 1 -C 6 )alkyl, optionally substituted cyclopropyl, optionally substituted cyclobutyl, optionally substituted cyclopentyl, optionally substituted phenyl, optionally substituted pyridazine, optionally substituted pyrazine, optionally substituted pyrimidine, optionally substituted pyrazole, optionally substituted pyrrolidine, optionally substituted quinazoline, optionally substituted pyridine, optionally substituted thiazolidine or optionally substituted triazole.
12. The method of claim 11 , wherein
A is a bond;
D is optionally substituted cyclopentylene, optionally substituted bicyclo[2.2.2]octanylene, optionally substituted azetidinyl, or optionally substituted piperidinyl;
E is —R e —C(O)—R e —, —R e —N(R a )—R e —, —R e —S(O) 2 N(R a )—R e , —R e —S(O) 2 —R e —, or —R e —N(R a )S(O) 2 —R e —;
wherein R e for each occurrence is independently a bond or an optionally substituted (C 1 -C 6 )alkylene; and
G is —CN, optionally substituted cyclopropyl, optionally substituted cyclobutyl, optionally substituted cyclopentyl, optionally substituted phenyl, optionally substituted pyrazine, optionally substituted pyridazine, optionally substituted pyrazole, or optionally substituted pyridine.
13. The method of claim 12 , wherein the compound is
14. The method of claim 12 , wherein the compound is
15. The method of claim 12 , wherein the compound is